Effect of supplementation in treatment of women with gestational diabetes

Phase 3

• Conditions: Gestational diabetes.; Diabetes mellitus in pregnancy, unspecified; O24.9

• Registration Number: IRCT201604195623N76
• Lead Sponsor: Vice chancellor for research, Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

Patients with gestational diabetes aged 18 to 40 years

Exclusion Criteria

Insulin-dependent diabetes
Smoking
History of kidney stones

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Expressed levels of insulin receptor 1 gene. Timepoint: Dlivery time. Method of measurement: PCR.;Expressed levels of insulin receptor 2 gene. Timepoint: Dlivery time. Method of measurement: PCR.

Secondary Outcome Measures

Name	Time	Method
Gene expression of PPAR-alpha. Timepoint: Delivery time. Method of measurement: PCR.;Gene expression of GLUT4. Timepoint: Delivery time. Method of measurement: PCR.;Gene expression of TGFB. Timepoint: Delivery time. Method of measurement: PCR.